Clinical Study

Significance of Semiquantitative Assessment of Preformed Donor-Specific Antibody Using Luminex Single Bead Assay in Living Related Liver Transplantation

Table 3

Risk factors for mortality.

CharacteristicsNumberMortality
% value*

Age0.245
  <18 years old30
  ≥18 years old1547
History of pregnancy0.367
  No825
  Yes1050
History of blood transfusion0.093
  No50
  Yes1155
  Unknown2
History of upper abdominal surgery0.335
  No922
  Yes956
Donor selection0.335
  Husband-son-daughter956
  Others922
Graft type0.358
 Right lobe1050
 Left lobe540
 Lateral segment30
GRWR0.245
  >0.81547
  <0.830
CDC1.000
  Negative1040
  Positive838
AHG-CDC$0.119
  Negative40
  Positive 1450
Mix assay Class I0.245
  Negative30
  Positive1547
FI of anti-Class I-DSA0.015
  Negative50
  Low20
  High1164
FI of anti-Class I-non-DSA0.110
  Negative30
  Low30
  High1258
Mix assay Class I0.205
  Negative1127
  Positive739
FI of anti-Class I-DSA0.057
  Negative1225
  Low3100
  High333
FI of anti-Class I-non-DSA
  Negative
  Low
  High
C4d staining 0.709
 Negative40
 Endothelial425
 Endothelial and stromal450

 *Fisher exact test; graft recipient weight ratio; compliment-dependent cytotoxicity; $anti-human globulin with added compliment-dependent cytotoxicity; fluorescence intensity of single antigen assay for anti-Class I donor-specific antibody (high, >10,000; low, <10,000).